Significant Ownership of Sofinnova Venture Partners X, L.P.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Sofinnova Venture Partners X, L.P. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Nathalie Auber - Nathalie Auber / Attorney-in-Fact
- Manager location
- Menlo Park, CA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Sofinnova Venture Partners X, L.P. with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Sofinnova Venture Partners X, L.P.
Significant Ownership of Sofinnova Venture Partners X, L.P.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | Class A Common Stock, $0.001 par value | 4% | $128,465,927 | 2,847,837 | Dr. Maha Katabi ("Katabi") | 10 Dec 2025 | ||
| JBIO | Jade Biosciences, Inc. | Common Stock, par value $0.0001 per share | 0.3% | $1,617,308 | 107,391 | Sofinnova Venture Partners X, L.P. ("SVP X") | 28 Apr 2025 |
Schedules 13D/G Reported by Sofinnova Venture Partners X, L.P.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.